Highest-materiality recent filing
James River Q1 2026 net loss $0.23/share vs prior year profit; adjusted net operating income $0.12
Net loss from continuing ops of $10.7M ($0.23 loss per share) vs income of $9.0M ($0.18 EPS) in Q1 2025.
James River posts Q4 net income of $30.1M vs loss of $94M YoY; combined ratio improves to 94.1%
Q4 2025 net income from continuing ops $30.15M ($0.53/diluted) vs loss of $92.67M ($2.25) in Q4 2024.
James River secures denial of Fleming's motion for reconsideration in securities fraud suit
U.S. District Court, Southern District of New York denied Fleming's motion for reconsideration on Dec 2, 2025.
James River Q3 net loss narrows to $0.01/share; adj net op income $0.32; $0.01 dividend
Net loss from continuing ops of $(0.01)/share vs $(1.07) YoY; adjusted net op income $0.32 vs $(0.74).
James River Group wins dismissal of Fleming securities fraud lawsuit
U.S. District Court, Southern District of New York granted dismissal on July 17, 2025.
James River Q1 EPS drops 66% YoY; E&S president retires; $0.01 dividend declared
Q1 net income from continuing ops $9.0M ($0.18 diluted), down from $20.9M ($0.53) YoY; adjusted net op income $9.1M ($0.19)
JRG Re sale price dispute resolved: only $483,625 adjustment, far below Fleming's $54.1M claim
Independent Accounting Firm ruled on disputed items from JRG Re sale: $483,625 downward adjustment, vs. Fleming's $54.1M claim.
James River Q4 2024 net loss $92.7M ($2.25/share); adjusted loss $40.8M
Net loss from continuing ops $92.7M ($2.25/diluted) vs income $17.4M ($0.46) in Q4 2023.
James River Group wins dismissal of securities class action with prejudice
U.S. District Court (SDNY) dismissed with prejudice the class action filed Nov 13, 2023 by Paul Glantz.
Exchanged 37,500 Series A Preferred for 5.9M common shares at $6.40/share; private placement of 1.95M shares to Cavello Bay for $12.5M.
James River Q3 net loss $1.10/dil; $52.2M E&S ADC charge drives loss
Net loss from continuing ops $40.7M ($1.07/dil); net loss available to common $42.0M ($1.10/dil).
James River Q2 adjusted EPS $0.33 (up 83% YoY); E&S combined ratio 95.4%; dividend $0.05
Net income from continuing ops $11.9M ($0.31 diluted), vs $9.5M ($0.25) in Q2 2023.
James River completes $160M LPT-ADC reinsurance with State National
State National reinsures 85% of E&S losses above $716.6M up to $467.1M limit; premium $313.2M.
James River Q1 net income from continuing ops $20.9M ($0.53 EPS) vs $5.3M ($0.14) YoY
Adjusted net operating income $14.8M ($0.39 diluted) vs $15.0M ($0.40) YoY.
James River completes sale of JRG Re for ~$291.4M; Heinlein departs
Closed sale of JRG Re to Fleming Intermediate Holdings for total consideration of ~$291.4M.
New York Supreme Court ordered Fleming to complete acquisition of JRG Reinsurance Company Ltd. by April 16, 2024.
James River sues Fleming to enforce sale of JRG Reinsurance subsidiary
Filed complaint in NY Supreme Court against Fleming Intermediate Holdings for breach of Stock Purchase Agreement dated Nov 8, 2023.
James River Q4 net loss $152.8M on JRG Re discontinued ops; sells reinsurer in Q1 2024
Net loss from discontinued ops of $170.2M includes $80.4M held-for-sale loss and $53.2M on fixed maturities.
James River board launches strategic alternatives review, including potential sale
Board will consider a wide range of options including sale, merger, or other strategic transaction.
James River Group sells JRG Reinsurance to Fleming Intermediate for up to $279.5M
Total consideration: $138M cash at closing, $139M pre-closing dividend/return of capital, plus up to $2.5M contingent payment.
James River restates Q1/Q2 2023 financials due to reinsurance premium error; Q3 net income $16.9M
Error in reinstatement premium accounting overstated net income by $7.8M (Q1) and $10.4M (H1 2023).
James River Group sells casualty reinsurance unit to Fleming for $277M
Total estimated transaction value of $277M, including $139M pre-closing dividend and $138M cash at close.
Core E&S renewal rates up 11% in Q2 2023, 26th consecutive quarter of increases.
James River Q2 net income $21.1M ($0.54 EPS) vs $5.0M; growth in premiums and investment income
Net income $21.1M ($0.54 diluted) vs $5.0M ($0.13) in Q2 2022; adjusted net operating income $20.6M ($0.53) vs $20.0M ($0.52).
On June 2, 2026, Mr. Langwell advised the Company of his resignation as a director of the Company, with effect from June 16, 2026.
Todd Sutherland will succeed him as President, also effective immediately.
On May 5, 2025, the Company announced that Richard J. Schmitzer, President and Chief Executive Officer of the Company’s Excess & Surplus Lines segment, in anticipation of his retirement from the Company later this year, will relinquish his President title effective immediately.
Mr. Schmitzer will also step down as Chief Executive Officer of the Company’s Excess & Surplus Lines segment, effective on July 31, 2025.
On February 27, 2025, Ollie L. Sherman, Jr. tendered his resignation as a director of the Company, with effect from April 30, 2025.
the Board named Christine LaSala, a current director, as the successor Non-Executive Chairperson of the Board, effective February 20, 2025.
On July 5, 2024, the Board of Directors (the “ Board ”) of the Company appointed Christine LaSala as a director of the Company.
On May 6, 2024, Patricia H. Roberts tendered her resignation as a director of the Company, with effect from May 15, 2024.
In connection with the Transaction, as of April 16, 2024, Daniel J. Heinlein, President and Chief Executive Officer of JRG Re, joined Buyer, and is no longer employed by a subsidiary of the Company.
As previously announced, Terence M. McCafferty, President and Chief Executive Officer of the Specialty Admitted Insurance segment of James River Group Holdings, Ltd. (the “Company”), left the Company effective December 2, 2023 (the “Separation Date”).
Effective December 2, 2023, Terence M. McCafferty, President and Chief Executive Officer of the Specialty Admitted Insurance segment of James River Group Holdings, Ltd. (the “Company”), is no longer with the Company.
On June 4, 2023, J. Adam Abram, the Non-Executive Chairman of the Board of James River Group Holdings, Ltd. (the “ Company ”), advised the Company that he does not intend to seek re-election as a director at the Company’s 2023 annual general meeting of shareholders
Max materiality 0.85 · Median 0.55 · Most common event other_material